Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 12Neoplasms 5Myelodysplastic Syndromes 5Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Recurrence 2Pathologic Complete Response 2Ovarian Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Lung Neoplasms 2Hodgkin Disease 2Breast Neoplasms 2Tumor Virus Infections 1Thyroid Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Cisplatin 41Gemcitabine 25Fluorouracil 15Radiotherapy, Intensity-Modulated 14Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5toripalimab 4spartalizumab 4Bevacizumab 4camrelizumab 3Nivolumab 3Induction Chemotherapy 3Endostatins 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Surveys and Questionnaires 2Polymerase Chain Reaction 2Nicotine 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nasopharyngeal Neoplasms × cc-486 × Clear all
NCT02269943 2018-12-12

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Celgene

Phase 2 Completed
36 enrolled 24 charts
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡